Navigation Links
US Cancer Vaccine Market Analysis
Date:9/17/2012

straints4.2.3.2.1 Engerix-B and Twinrix4.2.3.2.2 Recombivax HB and Comvax4.2.3.2.3 Pediarix5. Potential Cancer Vaccine Candidates: An Opportunity Assessment5.1 Prophylactic Vaccine5.2 Therapeutic Vaccine5.2.1 Prostate Cancer5.2.2 Breast Cancer5.2.3 Lung Cancer5.2.4 Colorectal Cancer6. Regulatory Environment6.1 Vaccine Approval Process6.2 FDA Guidance for Industry: Clinical Considerations for Therapeutic Cancer Vaccines6.2.1 Considerations for both Early and Late Phase Clinical Trials6.2.1.1 Patient Population6.2.1.2 Monitoring the Immune Response6.2.1.3 Biomarkers as Evidence of Efficacy6.2.1.4 Adjuvants Used to Stimulate Immune Response6.2.1.5 Multi-antigen Vaccines6.2.1.6 Disease Progression/Recurrence Immediately or Shortly after the Initial Administration of Cancer Vaccines6.2.1.7 Concomitant and Subsequent Therapies6.2.2 Considerations for Early Phase Clinical Trials6.2.2.1 Starting Dose and Dosing Schedule6.2.2.2 Booster and Maintenance Therapy6.2.2.3 Dose Escalation6.2.2.4 Single-arm versus Randomized Phase-2 Trials in Early Development6.2.3 Considerations for Late Phase Clinical Trials6.2.3.1 Safety Profile from Early Phase Clinical Trials6.2.3.2 Endpoints6.2.3.3 Statistical Issues6.2.3.4 Control Issues6.2.3.5 Delayed Vaccine Effect6.2.3.6 Autologous Vaccine Trials6.2.3.7 Accelerated Approval Regulations7. Competitive Landscape7.1 Merck & Co.7.1.1 Business Description7.1.2 Key Strategy Analysis7.2 GSK7.2.1 Business Description7.2.2 Key Strategy Analysis7.3 Dendreon7.3.1 Business Description7.3.2 Key Strategy Analysis7.4 Bavarian Nordic7.4.1 Business Description7.4.2 Key Strategy Analysis7.5 Celldex Therapeutics7.5.1 Business Description7.5.2 Key Strategy Analysis7.6 Kael-GemVax7.6.1 Business Description7.6.2 Key Strategy Analysis7.7 Oxford BioMedica7.7.1 Business Description7.7.2 Key Strategy Analysis7.8 Galena Biopharma7.8.1 Business Description7.8.2 Key Strategy Analysis

List of Figures:

Figure 3-1: Cancer Prevalence (Million), 2008-2016
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
2. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
3. Prostate Cancer: The End of Life As Men Know It?
4. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
5. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
6. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
7. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
8. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
9. Urologists And Henry Schein Team Up To Urge Families To Put A Prostate Cancer Check-Up On The Back To School List For Dad
10. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
11. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
(Date:6/30/2015)... 30, 2015  July 4 th is this weekend, ... the spirit and people behind it. To help honor our ... USA Medical Card, a leading provider ... programs that empower independence for our disabled military veterans, police, ... people afford their prescriptions. "Due to ...
(Date:6/30/2015)... WAYNE, Pa. , June 30, 2015 ... ("Egalet"), a fully integrated specialty pharmaceutical company ... pain treatments, today announced top-line results from ... study of Egalet-002, an abuse-deterrent, extended-release, oral ... for the management of pain severe enough ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Misonix, Inc. (Nasdaq: MSON ), a developer ... which worldwide is used for acute health conditions, today ... year ending June 30, 2010.  Michael A. McManus, Jr., ... VP and Chief Financial Officer, will host a conference ...
... YORK, Sept. 28 Reportlinker.com announces that a new ... Global In Vitro Diagnostics (IVD) Market Report: ... The global IVD market has been experiencing ... has been growing awareness about health and prevention of ...
Cached Medicine Technology:Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 2Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 3Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 4Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 5
(Date:6/30/2015)... ... ... Popular review portal HerpesDatingSites.org recently refreshed its user interface, ... the UI, the website hopes to benefit more users from across the globe. ... getting tougher. People are seeking professional assistance while searching for the best dating ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... As a subcontractor, ESSC ranked as one of their top 20 installing dealers ... last quarter of 2014. Providers are based on timeliness, service, installation, paperwork and ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down announces that they have slashed prices across the ... Pantages Theatre. For the past 26 years, “The Phantom of the Opera” has ... musical, originally written by Gaston Leroux, and converted into a musical by Andrew Lloyd Webber ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Ticket Down is a reliable source for last ... This legendary band has been packing stadiums across North America in conjunction with their 2015 ... they have the energy of a band in their twenties. Some of the most ...
(Date:6/30/2015)... Texas (PRWEB) , ... June 30, 2015 , ... ... ENT in Webster, Texas have launched a ‘responsive design’ website to inform potential ... available to cure them. , The website includes information about a wide variety ...
Breaking Medicine News(10 mins):Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3
... Total Fitness Holding,Corporation today announced that it has appointed ... July 1. Mr. Sheehan will also,serve as a member ... 46, served as the Chief Operating Officer of 24 ... Mr. Sheehan,served as Executive Vice President, Operations of 24 ...
... malfunction years later, researchers say , , TUESDAY, June ... way arteries respond to insulin, thereby increasing the ... pregnancy complication occurs, Scandinavian researchers report. , In ... insulin sensitivity in women and a history of ...
... GAINESVILLE, Fla. Devices known as brain-machine interfaces could ... amputees control prosthetic limbs with just their thoughts. Now, ... step further, devising a way for computerized devices not ... to evolve with the brain as it learns. , ...
... NEW YORK, June 24 According to the ... from diabetes,asthma and other chronic conditions. The medical care ... the nation,s $2 trillion medical care,costs. And as the ... its medical bills are expected to spiral further out ...
... WASHINGTON, June 24 With a latency period of ... mesothelioma, an,asbestos-generated cancer, the ravages of this life ending ... is hosting a press,conference with leadership, members of Congress ... of loss due to mesothelioma., The press conference ...
... Functional Food Snacks Contain Ingredients Medically Proven to Reduce ... Impact of ... In response to increasing,demand for convenient, tasty, satisfying ... disease, WatchDog Nutrition(TM) today announced,availability of its snack bars ...
Cached Medicine News:Health News:Bally Total Fitness Announces New Chief Executive Officer 2Health News:Preeclampsia Linked to Cardiovascular Problems After Pregnancy 2Health News:Preeclampsia Linked to Cardiovascular Problems After Pregnancy 3Health News:Researchers develop neural implant that learns with the brain 2Health News:Researchers develop neural implant that learns with the brain 3Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 2Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 3Health News:Faces of Mesothelioma; Meso Foundation Press Conference with Families and Patients 2Health News:Heart Disease and Diabetes Finally Meet Their Match With Delicious New Snack Bars From WatchDog Nutrition(TM) 2
... Stainless steel spiral reinforced. X-ray opaque . Low ... Flange: The flange can be adjusted along the ... cervical soft tissue. The lock ring is turned ... the shaft. Maximum Patient Comfort: The tube is ...
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
Thermosensitivity of material allows tube to conform to patients anatomy for maximum patient comfort....
Medicine Products: